FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
| | | | |

FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation

On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…

Nobel Prize in Chemistry awarded to David Baker “for computational protein design”;  Demis Hassabis and John M. Jumper “for protein structure prediction”
| | | | | | |

Nobel Prize in Chemistry awarded to David Baker “for computational protein design”; Demis Hassabis and John M. Jumper “for protein structure prediction”

On Oct. 9, 2024, the Nobel Foundation awarded the Nobel Prize in Chemistry: one half to David Baker,…